Priyashi Rao

Priyashi Rao

Auto-generated profile, based on publicly available information

Priyashi Rao

Department of Biochemistry and Forensic Science, University School of Sciences, Gujarat University, Ahmedabad, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Biophysical Chemistry
Verified
Journal Article
Closed access
PRPriyashi Rao
Priyashi Rao
ASArpit Shukla
Arpit Shukla
PPParitosh Parmar
Paritosh Parmar
RRRakesh M. Rawal
Rakesh M. Rawal
BPBaldev Patel
Baldev Patel
DGDweipayan Goswami
Dweipayan Goswami

1 September 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PRPriyashi Rao
Priyashi Rao
DGDweipayan Goswami
Dweipayan Goswami
RRRakesh M. Rawal
Rakesh M. Rawal
Emergence of vector borne diseases has continued to take toll on millions of lives since its inception. The use of insecticides began as vector control strategy in the early 1900’s but the menace of insects is still prevalent. Additionally, the inadequate use of organophosphates and carbamates which target acetylcholine esterase (AChE), are known to develop resistance amongst vectors of transmission and are toxic to humans. In this study, extensive computational screening was performed using homology modelling, molecular docking, molecular dynamics (MD) simulation and free energy change calculation, which highlighted curcumin as a lead molecule out of ~ 1700 phytochemicals against Culex pipiens AChE. In vivo larvicidal activity was carried out along with in vivo and in vitro AChE inhibition assay to determine the biochemical efficacy of curcumin. Our study reveals that curcumin induces mortality in Cx. pipiens at an early stage of its life cycle by AChE inhibition. This also underlines the use of curcumin as a coming-age natural product insecticide.


2 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VPVamangi Pandya
Vamangi Pandya
PRPriyashi Rao
Priyashi Rao
JPJignesh Prajapati
Jignesh Prajapati
RRRakesh M. Rawal
Rakesh M. Rawal
DGDweipayan Goswami
Dweipayan Goswami
Glycogen synthase kinase-3β (GSK3β) is a pivotal protein kinase implicated in a spectrum of debilitating diseases, encompassing cancer, diabetes, and neurodegenerative disorders. While the therapeutic potential of GSK3β inhibition is widely recognized, there remains an unmet need for a rigorous, systematic analysis probing the theoretical inhibition dynamics of a comprehensive library of indirubin derivatives against GSK3β using advanced computational methodologies. Addressing this gap, this study embarked on an ambitious endeavor, leveraging indirubin—a renowned scaffold—as a template to curate a vast library of 1000 indirubin derivatives from PubChem. These were enriched with varied substitutions and modifications, identified via a structure similarity search with a Tanimoto similarity threshold of 85%. Harnessing a robust virtual screening workflow, we meticulously identified the top 10 contenders based on XP docking scores. Delving deeper, we gauged the binding free energy differentials (ΔGBind) of these hits, spotlighting the top three compounds that showcased unparalleled binding prowess. A comparative pharmacophore feature mapping with the reference inhibitor OH8, co-crystallized with GSK3β (PDB ID: 6Y9R), was undertaken. The binding dynamics of these elite compounds were further corroborated with 100 ns molecular dynamics simulations, underlining their stable and potent interactions with GSK3β. Remarkably, our findings unveil that these indirubin derivatives not only match but, in certain scenarios, surpass the binding affinity and specificity of OH8. By bridging this research chasm, our study amplifies the therapeutic promise of indirubin derivatives, positioning them as frontrunners in the quest for groundbreaking GSK3β inhibitors, potentially revolutionizing treatments for a myriad of ailments.

24 April 2020 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
ASArpit Shukla
Arpit Shukla
PPParitosh Parmar
Paritosh Parmar
PRPriyashi Rao
Priyashi Rao
DGDweipayan Goswami
Dweipayan Goswami
MSMeenu Saraf
Meenu Saraf